Infinite Bio-Health Products Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 54.47%
- Profit Growth 79.92%
- Ebitda 134.32%
- Net Worth 237.45%
- Total Assets 20.37%
About Infinite Bio-Health Products
Infinite Bio-Health Products Private Limited (IBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2003 and has a history of 21 years and 11 months. Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen Thakkar, Jayesh Thakkar, Kalavati Thakkar, and Two other members serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2003PTC042017
-
Company No.
042017
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Feb 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Infinite Bio-Health Products?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Thakkar
|
Director | 14-Oct-2003 | Current |
|
Jayesh Thakkar
|
Director | 29-Sep-2004 | Current |
|
Kalavati Thakkar
|
Director | 21-Mar-2015 | Current |
|
Amritlal Thakkar
|
Director | 21-Mar-2015 | Current |
|
Debmallya Mandal
|
Director | 21-Mar-2015 | Current |
Financial Performance of Infinite Bio-Health Products.
Infinite Bio-Health Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.47% increase. The company also saw a substantial improvement in profitability, with a 79.92% increase in profit. The company's net worth Soared by an impressive increase of 237.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Infinite Bio-Health Products?
In 2023, Infinite Bio-Health Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Infinite Bio-Health Products?
Unlock and access historical data on people associated with Infinite Bio-Health Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infinite Bio-Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infinite Bio-Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.